SCHEMBL29358293

SCHEMBL29358293

O=C(O)C1=C[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](NS(=O)(=O)O)[C@@H](O[C@@H]3C(C(=O)O)OC(O[C@H]4[C@H](O)[C@@H](NS(=O)(=O)O)[C@@H](O[C@@H]5C(C(=O)O)OC(O[C@H]6[C@H](O)[C@@H](NS(=O)(=O)O)[C@@H](O[C@@H]7C(C(=O)O)OC(O[C@H]8[C@H](O)[C@@H](NS(=O)(=O)O)[C@@H](O)O[C@@H]8CO)[C@H](O)[C@H]7O)O[C@@H]6CO)[C@H](OS(=O)(=O)O)[C@H]5O)O[C@@H]4CO)[C@H](OS(=O)(=O)O)[C@H]3O)O[C@@H]2CO)O1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 3/20 0.56
▸ F2 P00734 1/20 0.40
▸ SERPINC1 P01008 1/20 0.40
▸ FGF1 P05230 2/20 0.39
▸ IFNG P01579 1/20 0.39
▸ FGF2 P09038 1/20 0.39
▸ BMP2 P12643 1/20 0.39
▸ VEGFA P15692 1/20 0.39
▸ SFRP1 Q8N474 1/20 0.39
▸ CXCL10 P02778 1/20 0.38
▸ CXCL8 P10145 1/20 0.38
▸ CCL2 P13500 1/20 0.38
▸ CCL5 P13501 1/20 0.38
▸ CXCL12 P48061 1/20 0.38
▸ HPSE Q9Y251 4/20 0.36
▸ BDNF P23560 2/20 0.35
▸ PTN P21246 1/20 0.35
▸ MDK P21741 1/20 0.35
▸ AMY2A P04746 2/20 0.35
▸ F8 P00451 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29352252 1.00 F10 (0.56) F10F2SERPINC1FGF1IFNG
SCHEMBL29361154 0.98 F10 (0.52) F10F2SERPINC1FGF1IFNG
SCHEMBL30043156 0.95 F10 (0.48) F10F2SERPINC1FGF1IFNG
SCHEMBL29399157 0.91 F10 (0.56) F10F2SERPINC1HPSEBDNF
SCHEMBL12300300 0.88 F10 (0.63) F10F2SERPINC1IFNGFGF2
SCHEMBL30041224 0.88 F10 (0.64) F10F2SERPINC1IFNGFGF2
SCHEMBL15395277 0.86 F10 (0.57) F10F2SERPINC1IFNGFGF2
SCHEMBL12532633 0.86 F10 (0.64) F10F2SERPINC1IFNGFGF2
SCHEMBL29647566 0.86 F10 (0.60) F10F2SERPINC1IFNGBMP2
SCHEMBL17167003 0.85 AMY2A (0.36) F10AMY2AGAAMGAMAMY1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118750150-A Pulse electric field and plasma combined generating device 金凤实验室 2024-10-11 — — CN claimed
CN-118312135-A Elliptic curve multi-scalar multiplication acceleration method, system and storage medium based on CUDA 武汉大学 2024-07-09 — — CN claimed
CN-118297783-A Vector map watermark embedding and extracting method and multistage watermark embedding and extracting method 苏州科技大学 2024-07-05 — — CN claimed
EP-4160979-A1 SEQUENCE ENCRYPTION METHOD FOR COMPOSITE REBUILD OF KEYS Xu, Zhineng (CN) 2023-04-05 — — EP claimed
CN-115208586-B Secret sharing-based digital signature method and system 中安网脉(北京)技术股份有限公司 2022-12-30 — — CN claimed
CN-114334060-B Medical data management method and system 四川执象网络有限公司 2022-11-04 — — CN claimed
CN-115208586-A Secret sharing-based digital signature method and system 中安网脉(北京)技术股份有限公司 2022-10-18 — — CN claimed
CN-111200093-B Ceramic particle and preparation method and application thereof 武汉中兴创新材料技术有限公司 2022-08-12 — — CN claimed
CN-111018096-B Aeration system maintenance device and method with two-dimensional dissolved oxygen detection and online cleaning functions 张梅 2022-08-12 — — CN claimed
CN-114635283-A Graphene composite animal hair material, preparation method thereof and animal hair product 北京蒙京石墨新材料科技研究院有限公司 2022-06-17 — — CN claimed
CN-114417229-A Two-dimensional calculation method for nuclear reactor steam explosion 西安交通大学 2022-04-29 — — CN claimed
CN-112026049-B Dry back-stage recovery unit of masterbatch 浙江汇隆新材料股份有限公司 2022-04-22 — — CN claimed
CN-114334060-A Medical data management method and system 四川执象网络有限公司 2022-04-12 — — CN claimed
US-20220038256-A1 SEQUENCE ENCRYPTION FOR REFACTORING RECONSTRUCTED-KEY XU ZHINENG (CN) 2022-02-03 — — US claimed
US-12640773-B2 Frequency hopping pattern indication method and apparatus HUAWEI TECHNOLOGIES CO., LTD. (CN) 2026-05-26 — — US disclosed
WO-2026098150-A1 BACKLIGHT MODULE, DISPLAY MODULE AND DISPLAY DEVICE 京东方科技集团股份有限公司 2026-05-15 — — WO disclosed
US-20260131375-A1 RIDGED TUNDISH STOPPER VESUVIUS GROUP, S.A. (BE) 2026-05-14 — — US disclosed
CN-215739868-U Eye protection instrument 陆英伟 2022-02-08 — — CN disclosed
US-20220038256-A1 SEQUENCE ENCRYPTION FOR REFACTORING RECONSTRUCTED-KEY XU ZHINENG (CN) 2022-02-03 — — US disclosed
US-20220024314-A1 DISPLAY DEVICE AND NON-TRANSITORY COMPUTER-READABLE STORAGE MEDIUM FOR DISPLAY CONTROL ON HEAD-UP DISPLAY DENSO CORPORATION (JP) 2022-01-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12640773-B2 Frequency hopping pattern indication method and apparatus GJB2, GJA1, FES F10 155/4885F2 102/4885SERPINC1 1822/4885
US-20260131375-A1 RIDGED TUNDISH STOPPER CTCF, RPL24, SRP72 F10 2988/4885F2 4398/4885SERPINC1 3844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback